Global Pneumonia Market Research Report 2023

Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.

The global Pneumonia market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.

This report aims to provide a comprehensive presentation of the global market for Pneumonia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumonia.

The Pneumonia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pneumonia market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pneumonia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pneumonia Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Drugs

1.2.3 Vaccines

1.2.4 Oxygen Therapy

1.3 Market by Application

1.3.1 Global Pneumonia Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Pneumonia Market Perspective (2018-2029)

2.2 Pneumonia Growth Trends by Region

2.2.1 Global Pneumonia Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pneumonia Historic Market Size by Region (2018-2023)

2.2.3 Pneumonia Forecasted Market Size by Region (2024-2029)

2.3 Pneumonia Market Dynamics

2.3.1 Pneumonia Industry Trends

2.3.2 Pneumonia Market Drivers

2.3.3 Pneumonia Market Challenges

2.3.4 Pneumonia Market Restraints

3.1 Global Top Pneumonia Players by Revenue

3.1.1 Global Top Pneumonia Players by Revenue (2018-2023)

3.1.2 Global Pneumonia Revenue Market Share by Players (2018-2023)

3.2 Global Pneumonia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pneumonia Revenue

3.4 Global Pneumonia Market Concentration Ratio

3.4.1 Global Pneumonia Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Revenue in 2022

3.5 Pneumonia Key Players Head office and Area Served

3.6 Key Players Pneumonia Product Solution and Service

3.7 Date of Enter into Pneumonia Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Pneumonia Historic Market Size by Type (2018-2023)

4.2 Global Pneumonia Forecasted Market Size by Type (2024-2029)

5.1 Global Pneumonia Historic Market Size by Application (2018-2023)

5.2 Global Pneumonia Forecasted Market Size by Application (2024-2029)

6.1 North America Pneumonia Market Size (2018-2029)

6.2 North America Pneumonia Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Pneumonia Market Size by Country (2018-2023)

6.4 North America Pneumonia Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Pneumonia Market Size (2018-2029)

7.2 Europe Pneumonia Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Pneumonia Market Size by Country (2018-2023)

7.4 Europe Pneumonia Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Pneumonia Market Size (2018-2029)

8.2 Asia-Pacific Pneumonia Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Pneumonia Market Size by Region (2018-2023)

8.4 Asia-Pacific Pneumonia Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Pneumonia Market Size (2018-2029)

9.2 Latin America Pneumonia Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Pneumonia Market Size by Country (2018-2023)

9.4 Latin America Pneumonia Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Pneumonia Market Size (2018-2029)

10.2 Middle East & Africa Pneumonia Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Pneumonia Market Size by Country (2018-2023)

10.4 Middle East & Africa Pneumonia Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Pneumonia Introduction

11.1.4 Pfizer Revenue in Pneumonia Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 GlaxoSmithKline(GSK)

11.2.1 GlaxoSmithKline(GSK) Company Detail

11.2.2 GlaxoSmithKline(GSK) Business Overview

11.2.3 GlaxoSmithKline(GSK) Pneumonia Introduction

11.2.4 GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2018-2023)

11.2.5 GlaxoSmithKline(GSK) Recent Development

11.3 Merck

11.3.1 Merck Company Detail

11.3.2 Merck Business Overview

11.3.3 Merck Pneumonia Introduction

11.3.4 Merck Revenue in Pneumonia Business (2018-2023)

11.3.5 Merck Recent Development

11.4 Novartis

11.4.1 Novartis Company Detail

11.4.2 Novartis Business Overview

11.4.3 Novartis Pneumonia Introduction

11.4.4 Novartis Revenue in Pneumonia Business (2018-2023)

11.4.5 Novartis Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Pneumonia Introduction

11.5.4 Sanofi Revenue in Pneumonia Business (2018-2023)

11.5.5 Sanofi Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Detail

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Pneumonia Introduction

11.6.4 Eli Lilly Revenue in Pneumonia Business (2018-2023)

11.6.5 Eli Lilly Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Pneumonia Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Drugs

    Table 3. Key Players of Vaccines

    Table 4. Key Players of Oxygen Therapy

    Table 5. Global Pneumonia Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Pneumonia Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Pneumonia Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Pneumonia Market Share by Region (2018-2023)

    Table 9. Global Pneumonia Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Pneumonia Market Share by Region (2024-2029)

    Table 11. Pneumonia Market Trends

    Table 12. Pneumonia Market Drivers

    Table 13. Pneumonia Market Challenges

    Table 14. Pneumonia Market Restraints

    Table 15. Global Pneumonia Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Pneumonia Market Share by Players (2018-2023)

    Table 17. Global Top Pneumonia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia as of 2022)

    Table 18. Ranking of Global Top Pneumonia Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Pneumonia Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Pneumonia Product Solution and Service

    Table 22. Date of Enter into Pneumonia Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Pneumonia Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Pneumonia Revenue Market Share by Type (2018-2023)

    Table 26. Global Pneumonia Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Pneumonia Revenue Market Share by Type (2024-2029)

    Table 28. Global Pneumonia Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Pneumonia Revenue Market Share by Application (2018-2023)

    Table 30. Global Pneumonia Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Pneumonia Revenue Market Share by Application (2024-2029)

    Table 32. North America Pneumonia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Pneumonia Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Pneumonia Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Pneumonia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Pneumonia Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Pneumonia Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Pneumonia Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Pneumonia Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Pneumonia Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Pneumonia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Pneumonia Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Pneumonia Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Pneumonia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Pneumonia Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Pneumonia Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Pfizer Company Detail

    Table 48. Pfizer Business Overview

    Table 49. Pfizer Pneumonia Product

    Table 50. Pfizer Revenue in Pneumonia Business (2018-2023) & (US$ Million)

    Table 51. Pfizer Recent Development

    Table 52. GlaxoSmithKline(GSK) Company Detail

    Table 53. GlaxoSmithKline(GSK) Business Overview

    Table 54. GlaxoSmithKline(GSK) Pneumonia Product

    Table 55. GlaxoSmithKline(GSK) Revenue in Pneumonia Business (2018-2023) & (US$ Million)

    Table 56. GlaxoSmithKline(GSK) Recent Development

    Table 57. Merck Company Detail

    Table 58. Merck Business Overview

    Table 59. Merck Pneumonia Product

    Table 60. Merck Revenue in Pneumonia Business (2018-2023) & (US$ Million)

    Table 61. Merck Recent Development

    Table 62. Novartis Company Detail

    Table 63. Novartis Business Overview

    Table 64. Novartis Pneumonia Product

    Table 65. Novartis Revenue in Pneumonia Business (2018-2023) & (US$ Million)

    Table 66. Novartis Recent Development

    Table 67. Sanofi Company Detail

    Table 68. Sanofi Business Overview

    Table 69. Sanofi Pneumonia Product

    Table 70. Sanofi Revenue in Pneumonia Business (2018-2023) & (US$ Million)

    Table 71. Sanofi Recent Development

    Table 72. Eli Lilly Company Detail

    Table 73. Eli Lilly Business Overview

    Table 74. Eli Lilly Pneumonia Product

    Table 75. Eli Lilly Revenue in Pneumonia Business (2018-2023) & (US$ Million)

    Table 76. Eli Lilly Recent Development

    Table 77. Research Programs/Design for This Report

    Table 78. Key Data Information from Secondary Sources

    Table 79. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Pneumonia Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Pneumonia Market Share by Type: 2022 VS 2029

    Figure 3. Drugs Features

    Figure 4. Vaccines Features

    Figure 5. Oxygen Therapy Features

    Figure 6. Global Pneumonia Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Pneumonia Market Share by Application: 2022 VS 2029

    Figure 8. Hospitals Case Studies

    Figure 9. Ambulatory Surgical Centers Case Studies

    Figure 10. Others Case Studies

    Figure 11. Pneumonia Report Years Considered

    Figure 12. Global Pneumonia Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Pneumonia Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Pneumonia Market Share by Region: 2022 VS 2029

    Figure 15. Global Pneumonia Market Share by Players in 2022

    Figure 16. Global Top Pneumonia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Pneumonia Revenue in 2022

    Figure 18. North America Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Pneumonia Market Share by Country (2018-2029)

    Figure 20. United States Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Pneumonia Market Share by Country (2018-2029)

    Figure 24. Germany Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Pneumonia Market Share by Region (2018-2029)

    Figure 32. China Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Pneumonia Market Share by Country (2018-2029)

    Figure 40. Mexico Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Pneumonia Market Share by Country (2018-2029)

    Figure 44. Turkey Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Pneumonia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Pfizer Revenue Growth Rate in Pneumonia Business (2018-2023)

    Figure 47. GlaxoSmithKline(GSK) Revenue Growth Rate in Pneumonia Business (2018-2023)

    Figure 48. Merck Revenue Growth Rate in Pneumonia Business (2018-2023)

    Figure 49. Novartis Revenue Growth Rate in Pneumonia Business (2018-2023)

    Figure 50. Sanofi Revenue Growth Rate in Pneumonia Business (2018-2023)

    Figure 51. Eli Lilly Revenue Growth Rate in Pneumonia Business (2018-2023)

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation

    Figure 54. Key Executives Interviewed